View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Market Data
July 7, 2016

M&As this week: Accuron Technologies, Nantong Jinghua Pharma

Accuron Technologies plans to further develop its suite of medical devices outsourcing services through its recent acquisition of a majority stake in Aurum Healthcare, a provider of sterilisation services for medical devices and instruments.

Accuron Technologies plans to further develop its suite of medical devices outsourcing services through its recent acquisition of a majority stake in Aurum Healthcare , a provider of sterilisation services for medical devices and instruments.

"Nantong Jinghua Pharma will become a 78.3% stakeholder in Jiangsu Kingsley Pharmaceuticals."

According to the agreement, Accuron Technologies will place Aurum Healthcare under its Advanced Materials Technologies (AMT ) business in order to increase AMT ‘s manufacturing footprint.

Nantong Jinghua Pharma, a Chinese traditional pharma products manufacturer, plans to acquire an additional 29.73% stake in Jiangsu Kingsley Pharmaceuticals.

Following the transaction, Nantong Jinghua Pharma will become a 78.3% stakeholder in Jiangsu Kingsley Pharmaceuticals.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena